drug

arimoclomol

2 stories · latest Aug 5, 2026

Timeline

Zevra reports Q2 2026 results as MIPLYFFA revenue grows and EU review continues

Aug 5Quarterly updatearimoclomol Zevra Therapeutics, Inc.

Ligand closes $739 million acquisition of XOMA Royalty

Jul 14M&ALigand Pharmaceuticals Inc